Your session is about to expire
← Back to Search
Fatty Acid Supplement
C15:0 Supplementation for Metabolic Syndrome in Young Adults
N/A
Waitlist Available
Led By Jeffrey Schwimmer, MD
Research Sponsored by Jeffrey B. Schwimmer, MD
Eligibility Criteria Checklist
Specific guidelines that determine who can or cannot participate in a clinical trial Must have
Be between 18 and 65 years old
Timeline
Screening 3 weeks
Treatment Varies
Follow Up baseline to 12 weeks
Awards & highlights
Summary
This trial will see if adding a type of saturated fat to one's diet affects their BMI.
Eligible Conditions
- Metabolic Syndrome
Timeline
Screening ~ 3 weeks3 visits
Treatment ~ Varies
Follow Up ~ baseline to 12 weeks
Screening ~ 3 weeks
Treatment ~ Varies
Follow Up ~baseline to 12 weeks
Treatment Details
Study Objectives
Study objectives can provide a clearer picture of what you can expect from a treatment.Primary study objectives
Change in plasma C15:0 levels
Secondary study objectives
Change in BMI
Change in High Sensitivity C-reactive protein
Change in Weight
+10 moreTrial Design
2Treatment groups
Active Control
Placebo Group
Group I: ActiveActive Control1 Intervention
200mg of pentadecanoic acid (C15:0) supplementation in capsules form
Group II: PlaceboPlacebo Group1 Intervention
Matching placebo in capsules form
Find a Location
Who is running the clinical trial?
Jeffrey B. Schwimmer, MDLead Sponsor
Jeffrey Schwimmer, MDPrincipal InvestigatorUC San Diego
1 Previous Clinical Trials
20 Total Patients Enrolled
Media Library
Eligibility Criteria:
This trial includes the following eligibility criteria:- You are currently taking statin medications.You weigh more than 125 kilograms at the time of screening.Your triglyceride levels are higher than 500 mg/dL.You are currently taking Omega 3 Fatty Acid supplements.You regularly eat more than 250 milligrams of C15:0 in your diet every day.You drink a lot of alcohol regularly or have episodes of heavy drinking.You cannot swallow pills or capsules.You have either type 1 or type 2 diabetes.You have liver cirrhosis.Your LDL-cholesterol level is higher than 160 mg/dL.Your hemoglobin level is lower than 10.0 grams per deciliter.You are between 18 and 25 years old.You weigh more than what is considered healthy for your height.
Research Study Groups:
This trial has the following groups:- Group 1: Active
- Group 2: Placebo
Awards:
This trial has 0 awards, including:Timeline:
This trial has the following timeline:- Screening: It may take up to 3 Weeks to process to see if you qualify in this trial.
- Treatment: The duration you will receive the treatment varies.
- Follow Ups: You may be asked to continue sharing information regarding the trial for 6 Months after you stop receiving the treatment.
Other Trials to Consider
Popular Categories
Share this study with friends
Copy Link
Messenger